§01 Browse › Superdrol

Superdrol

Methasterone Methyldrostanolone SD M-Drol Sdrol
Hepatotoxic DHT Derivative Advanced Only Severe Suppression
Extreme potency Ultra-hepatotoxic
Pharmacology detail: animal ratings

These ratios are not measured human benefit or safety rankings.

Anabolic / Androgenic
400 20
20.0:1 vs testosterone baseline
Aromatizes No
Hepatotoxic Yes
Oral Yes
Suppression severe
PCT Required

This profile covers Superdrol. Compare the ingredient, formulation and evidence with compounds you already recognize, then read the risks.

Technical catalog description

Superdrol (Methasterone) is a modified DHT derivative that was briefly sold as a ‘prohormone’ supplement before being banned. It’s considered one of the most anabolic steroids per milligram, often called ‘the nuclear bomb of steroids’ due to its extreme potency and equally extreme side effects.

Superdrol delivers very dry gains without water retention, as it doesn’t convert to estrogen. Users commonly report gaining 10-20 pounds of lean muscle in just a few weeks, with dramatic strength increases and muscle fullness. The compound produces insane pumps and a euphoric training high that some compare to stimulants.

Overview Use context Comparison Safety
Warning
EXTREME hepatotoxicity - can cause liver failure in weeks · Severe lethargy and fatigue despite muscle growth · Dangerous blood pressure spikes and electrolyte disturbances · Can cause hyperkalemia and chest pain · Profound post-cycle depression from dopamine crash · Many users cannot complete planned cycle length

Read next

Overview
Mechanism details

Superdrol is a methylated DHT derivative originally marketed as a prohormone supplement because it could be sold legally before reclassification as a controlled substance. Its pharmacological profile is closer to an extremely potent oral steroid than to traditional prohormones. It does not aromatize, so estrogen is not the primary management concern, but this also means the gains are dry and the side effects are direct rather than mediated through estrogenic pathways.

The acute hepatotoxicity is the defining feature. ALT and AST can reach 5–10x normal range within 2–3 weeks of use. Cholestatic jaundice has been documented. Bilirubin elevation is a serious warning sign. This profile does not establish a tolerable cycle duration.

The “pump” effect on Superdrol is frequently described as more pain than pleasure. Calf and back pumps during training can be severe enough to force workout modifications. This is SHBG reduction combined with extreme glycogen and creatine loading driven by the anabolic activity.

The dopamine and CNS stimulation during use creates a subjective high that contributes to the crash post-cycle. Users who run Superdrol frequently describe feeling dysphoric and depleted for 1–4 weeks after stopping, beyond normal HPTA suppression.

Safety & monitoring
Side effects
  • Natural suppression with reduced fertility and testicular output

  • Acne, oily skin, scalp hair loss, and prostate irritation in susceptible users

  • Liver stress, appetite disruption, and worse lipids with oral use

  • Disproportionate toxicity relative to the amount of useful training progress most users get

Monitoring
  • CBC / hematocrit

  • blood pressure

  • lipid panel

  • ALT / AST / GGT

  • bilirubin

  • PSA if age or symptoms justify it

Avoid if
  • Uncontrolled hypertension or untreated cardiovascular disease

  • Pre-existing severe infertility concerns unless that risk is accepted and managed

  • Active liver disease or already-elevated liver enzymes before starting

  • Aggressive hair loss history or significant prostate symptoms

  • First-cycle or low-experience use

Use context

Superdrol is chosen for concentrated bursts of lean mass gain in users who have exhausted more sustainable options or who want maximum output in a short, highly bounded window. The lean mass produced is real, unlike Dianabol or Anadrol, there is no water component to distinguish. But the cost-to-benefit ratio is poor for most users compared to better-tolerated alternatives.

Timeline & expectations

Days 1–7: Initial strength and pump increase. Lethargy may begin within the first week.
Weeks 2–4: Peak anabolic output. Liver markers are now meaningfully elevated. Most users stop here due to systemic feel.
After 4 weeks: The hepatic cost has already been paid. Most users should not continue.

Common mistakes

Extending exposure because the anabolic feel is good. This profile does not establish a safe duration.

Relying on liver support supplements to make longer exposure safe. This catalog does not validate a supplement amount or a cycle duration that offsets the toxicity concerns discussed here.

Unverified community monitoring practice: Discussions mention weekly or biweekly liver-enzyme testing. This catalog does not validate a monitoring interval that makes exposure safe.

Comparison notes

Compared with Anadrol, Superdrol produces drier gains with less fluid accumulation but typically worse hepatic and systemic tolerability. Anadrol’s side effects are uncomfortable; Superdrol’s can feel medically concerning. For a harsh oral bulk, Anadrol is usually the more appropriate first choice.

Compared with Dianabol, Superdrol is less forgiving in every dimension. The gain quality is better (dryer, more lean), but the cost in liver stress, lethargy, and post-cycle recovery is substantially higher. For users who have not yet exhausted Dianabol, there is rarely a reason to escalate to Superdrol.

Record quantities in the builder Read: Beyond Testosterone and Deca: Comparing Steroid Families ← Browse